Bristol (The COW News Digital)Scientists at the University of Bristol in the United Kingdom have achieved a significant breakthrough in Alzheimer’s disease research by successfully converting a gene associated with a higher risk of the condition into a comparatively safer genetic variant.
Researchers used advanced genetic technology to convert the APOE4 gene into APOE3 in human cells, raising hopes for a potential new approach to preventing and treating Alzheimer’s disease.
According to the research team, the technology could eventually be delivered through a single injection, potentially offering a new way to reduce the risk of developing the progressive neurological disorder. However, further research and clinical trials will be required before the approach can be considered for routine medical treatment.
Alzheimer’s disease is the most common form of dementia, a condition that gradually affects memory, thinking abilities and everyday functioning. In the United Kingdom, approximately 60 percent of the nearly one million people living with dementia are affected by Alzheimer’s disease.
Researchers have identified the APOE4 gene as one of the strongest known genetic risk factors associated with Alzheimer’s. In comparison, APOE3 is generally considered a lower-risk variant.
The study focused on changing the genetic variant rather than simply targeting the symptoms associated with the disease. By converting APOE4 into APOE3 in human cells, scientists demonstrated a potential way of addressing an important genetic factor linked to Alzheimer’s.
The findings are particularly significant because APOE4 is relatively common in the general population. Research estimates suggest that approximately one in four people carries at least one copy of this genetic variant, while around one in 50 carries two copies.
Experts emphasize that carrying the APOE4 gene does not mean a person will inevitably develop Alzheimer’s disease. However, its presence can substantially increase the likelihood of developing the condition, particularly among individuals carrying two copies.
The latest research could therefore open new possibilities for people with an increased genetic risk of Alzheimer’s, although scientists caution that laboratory success does not automatically translate into an effective treatment for patients.
If future studies establish the safety and effectiveness of this genetic approach, it could potentially lead to preventive treatments designed to reduce the influence of inherited risk factors before significant brain damage occurs.
Meanwhile, health experts continue to highlight the importance of lifestyle choices in maintaining brain health. Regular physical activity, maintaining social connections and staying mentally and physically active may help reduce the risk of cognitive decline.
Scientists believe that combining advances in genetic research with preventive healthcare could eventually improve strategies for tackling Alzheimer’s disease.
Although the conversion of APOE4 into APOE3 marks an encouraging scientific development, researchers stress that substantial work remains before the technology can be tested and approved for widespread use in humans.
The breakthrough offers fresh hope in the global fight against dementia and could contribute to the development of new genetic therapies in the years ahead.
